시장조사 보고서 : 세계의 데메롤 (메페리딘) 시장예측 2021년-2026년

■ 영문 제목 : Global Demerol (Meperidine) Market Growth 2021-2026
	■ 상품코드 : LPI-2108K201259 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 136 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 데메롤 (메페리딘)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (분말, 액체)와 용도별 시장규모 (마취, 기침 치료, 설사 치료) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 데메롤 (메페리딘) 시장 점유율
- 지역별 데메롤 (메페리딘) 시장규모
- 주요지역의 종류별 시장규모 (분말, 액체)
- 주요지역의 용도별 시장규모 (마취, 기침 치료, 설사 치료)
- 미주의 데메롤 (메페리딘) 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 데메롤 (메페리딘) 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 데메롤 (메페리딘) 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 데메롤 (메페리딘) 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 데메롤 (메페리딘) 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Demerol (Meperidine) will have significant change from previous year. By the most conservative estimates of global Demerol (Meperidine) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Demerol (Meperidine) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Demerol (Meperidine) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Powder
Liquid

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Anesthesia
Cough Treatment
Diarrhea Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Demerol (Meperidine) Consumption 2016-2026
2.1.2 Demerol (Meperidine) Consumption CAGR by Region
2.2 Demerol (Meperidine) Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.3 Demerol (Meperidine) Sales by Type
2.3.1 Global Demerol (Meperidine) Sales Market Share by Type (2016-2021)
2.3.2 Global Demerol (Meperidine) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Demerol (Meperidine) Sale Price by Type (2016-2021)
2.4 Demerol (Meperidine) Segment by Application
2.4.1 Anesthesia
2.4.2 Cough Treatment
2.4.3 Diarrhea Treatment
2.5 Demerol (Meperidine) Sales by Application
2.5.1 Global Demerol (Meperidine) Sale Market Share by Application (2016-2021)
2.5.2 Global Demerol (Meperidine) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Demerol (Meperidine) Sale Price by Application (2016-2021)

3 Global Demerol (Meperidine) by Company
3.1 Global Demerol (Meperidine) Sales Market Share by Company
3.1.1 Global Demerol (Meperidine) Sales by Company (2019-2021)
3.1.2 Global Demerol (Meperidine) Sales Market Share by Company (2019-2021)
3.2 Global Demerol (Meperidine) Revenue Market Share by Company
3.2.1 Global Demerol (Meperidine) Revenue by Company (2019-2021)
3.2.2 Global Demerol (Meperidine) Revenue Market Share by Company (2019-2021)
3.3 Global Demerol (Meperidine) Sale Price by Company
3.4 Global Manufacturers Demerol (Meperidine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Demerol (Meperidine) Product Location Distribution
3.4.2 Players Demerol (Meperidine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Demerol (Meperidine) by Region
4.1 Global Demerol (Meperidine) by Region
4.1.1 Global Demerol (Meperidine) Sales by Region
4.1.2 Global Demerol (Meperidine) Revenue by Region
4.2 Americas Demerol (Meperidine) Sales Growth
4.3 APAC Demerol (Meperidine) Sales Growth
4.4 Europe Demerol (Meperidine) Sales Growth
4.5 Middle East & Africa Demerol (Meperidine) Sales Growth

5 Americas
5.1 Americas Demerol (Meperidine) Sales by Country
5.1.1 Americas Demerol (Meperidine) Sales by Country (2016-2021)
5.1.2 Americas Demerol (Meperidine) Revenue by Country (2016-2021)
5.2 Americas Demerol (Meperidine) Sales by Type
5.3 Americas Demerol (Meperidine) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Demerol (Meperidine) Sales by Region
6.1.1 APAC Demerol (Meperidine) Sales by Region (2016-2021)
6.1.2 APAC Demerol (Meperidine) Revenue by Region (2016-2021)
6.2 APAC Demerol (Meperidine) Sales by Type
6.3 APAC Demerol (Meperidine) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Demerol (Meperidine) by Country
7.1.1 Europe Demerol (Meperidine) Sales by Country (2016-2021)
7.1.2 Europe Demerol (Meperidine) Revenue by Country (2016-2021)
7.2 Europe Demerol (Meperidine) Sales by Type
7.3 Europe Demerol (Meperidine) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Demerol (Meperidine) by Country
8.1.1 Middle East & Africa Demerol (Meperidine) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Demerol (Meperidine) Revenue by Country (2016-2021)
8.2 Middle East & Africa Demerol (Meperidine) Sales by Type
8.3 Middle East & Africa Demerol (Meperidine) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Demerol (Meperidine) Distributors
10.3 Demerol (Meperidine) Customer

11 Global Demerol (Meperidine) Market Forecast
11.1 Global Demerol (Meperidine) Forecast by Region
11.1.1 Global Demerol (Meperidine) Forecast by Regions (2021-2026)
11.2.2 Global Demerol (Meperidine) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Demerol (Meperidine) Forecast by Type
11.7 Global Demerol (Meperidine) Forecast by Application

12 Key Players Analysis
12.1 Purdue Pharma
12.1.1 Purdue Pharma Purdue Pharma Company Information
12.1.2 Purdue Pharma Demerol (Meperidine) Product Offered
12.1.3 Purdue Pharma Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Purdue Pharma Main Business Overview
12.1.5 Purdue Pharma Latest Developments
12.2 Egalet
12.2.1 Egalet Company Information
12.2.2 Egalet Demerol (Meperidine) Product Offered
12.2.3 Egalet Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Egalet Main Business Overview
12.2.5 Egalet Latest Developments
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Information
12.3.2 Boehringer Ingelheim Demerol (Meperidine) Product Offered
12.3.3 Boehringer Ingelheim Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Boehringer Ingelheim Main Business Overview
12.3.5 Boehringer Ingelheim Latest Developments
12.4 Janssen
12.4.1 Janssen Company Information
12.4.2 Janssen Demerol (Meperidine) Product Offered
12.4.3 Janssen Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Janssen Main Business Overview
12.4.5 Janssen Latest Developments
12.5 Sanofi
12.5.1 Sanofi Company Information
12.5.2 Sanofi Demerol (Meperidine) Product Offered
12.5.3 Sanofi Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sanofi Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Sun Pharmaceuticals
12.6.1 Sun Pharmaceuticals Company Information
12.6.2 Sun Pharmaceuticals Demerol (Meperidine) Product Offered
12.6.3 Sun Pharmaceuticals Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Sun Pharmaceuticals Main Business Overview
12.6.5 Sun Pharmaceuticals Latest Developments
12.7 Mallinckrodt Pharmaceuticals
12.7.1 Mallinckrodt Pharmaceuticals Company Information
12.7.2 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Product Offered
12.7.3 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Mallinckrodt Pharmaceuticals Main Business Overview
12.7.5 Mallinckrodt Pharmaceuticals Latest Developments
12.8 Endo Pharmaceuticals
12.8.1 Endo Pharmaceuticals Company Information
12.8.2 Endo Pharmaceuticals Demerol (Meperidine) Product Offered
12.8.3 Endo Pharmaceuticals Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Endo Pharmaceuticals Main Business Overview
12.8.5 Endo Pharmaceuticals Latest Developments
12.9 Actavis
12.9.1 Actavis Company Information
12.9.2 Actavis Demerol (Meperidine) Product Offered
12.9.3 Actavis Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Actavis Main Business Overview
12.9.5 Actavis Latest Developments
12.10 Pfizer
12.10.1 Pfizer Company Information
12.10.2 Pfizer Demerol (Meperidine) Product Offered
12.10.3 Pfizer Demerol (Meperidine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Pfizer Main Business Overview
12.10.5 Pfizer Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Demerol (Meperidine) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Powder
Table 3. Major Players of Liquid
Table 4. Global Demerol (Meperidine) Sales by Type (2016-2021) & (K MT)
Table 5. Global Demerol (Meperidine) Sales Market Share by Type (2016-2021)
Table 6. Global Demerol (Meperidine) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Demerol (Meperidine) Revenue Market Share by Type (2016-2021)
Table 8. Global Demerol (Meperidine) Sale Price by Type (2016-2021)
Table 9. Global Demerol (Meperidine) Sales by Application (2016-2021) & (K MT)
Table 10. Global Demerol (Meperidine) Sales Market Share by Application (2016-2021)
Table 11. Global Demerol (Meperidine) Value by Application (2016-2021)
Table 12. Global Demerol (Meperidine) Revenue Market Share by Application (2016-2021)
Table 13. Global Demerol (Meperidine) Sale Price by Application (2016-2021)
Table 14. Global Demerol (Meperidine) Sales by Company (2019-2021) & (K MT)
Table 15. Global Demerol (Meperidine) Sales Market Share by Company (2019-2021)
Table 16. Global Demerol (Meperidine) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Demerol (Meperidine) Revenue Market Share by Company (2019-2021)
Table 18. Global Demerol (Meperidine) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Demerol (Meperidine) Producing Area Distribution and Sales Area
Table 20. Players Demerol (Meperidine) Products Offered
Table 21. Demerol (Meperidine) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Demerol (Meperidine) Sales by Region (2016-2021) (K MT)
Table 25. Global Demerol (Meperidine) Sales Market Share by Region (2016-2021)
Table 26. Global Demerol (Meperidine) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Demerol (Meperidine) Revenue Market Share by Region (2016-2021)
Table 28. Americas Demerol (Meperidine) Sales by Country (2016-2021) & (K MT)
Table 29. Americas Demerol (Meperidine) Sales Market Share by Country (2016-2021)
Table 30. Americas Demerol (Meperidine) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Demerol (Meperidine) Revenue Market Share by Country (2016-2021)
Table 32. Americas Demerol (Meperidine) Sales by Type (2016-2021) & (K MT)
Table 33. Americas Demerol (Meperidine) Sales Market Share by Type (2016-2021)
Table 34. Americas Demerol (Meperidine) Sales by Application (2016-2021) & (K MT)
Table 35. Americas Demerol (Meperidine) Sales Market Share by Application (2016-2021)
Table 36. APAC Demerol (Meperidine) Sales by Region (2016-2021) & (K MT)
Table 37. APAC Demerol (Meperidine) Sales Market Share by Region (2016-2021)
Table 38. APAC Demerol (Meperidine) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Demerol (Meperidine) Revenue Market Share by Region (2016-2021)
Table 40. APAC Demerol (Meperidine) Sales by Type (2016-2021) & (K MT)
Table 41. APAC Demerol (Meperidine) Sales Market Share by Type (2016-2021)
Table 42. APAC Demerol (Meperidine) Sales by Application (2016-2021) & (K MT)
Table 43. APAC Demerol (Meperidine) Sales Market Share by Application (2016-2021)
Table 44. Europe Demerol (Meperidine) Sales by Country (2016-2021) & (K MT)
Table 45. Europe Demerol (Meperidine) Sales Market Share by Country (2016-2021)
Table 46. Europe Demerol (Meperidine) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Demerol (Meperidine) Revenue Market Share by Country (2016-2021)
Table 48. Europe Demerol (Meperidine) Sales by Type (2016-2021) & (K MT)
Table 49. Europe Demerol (Meperidine) Sales Market Share by Type (2016-2021)
Table 50. Europe Demerol (Meperidine) Sales by Application (2016-2021) & (K MT)
Table 51. Europe Demerol (Meperidine) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Demerol (Meperidine) Sales by Country (2016-2021) & (K MT)
Table 53. Middle East & Africa Demerol (Meperidine) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Demerol (Meperidine) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Demerol (Meperidine) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Demerol (Meperidine) Sales by Type (2016-2021) & (K MT)
Table 57. Middle East & Africa Demerol (Meperidine) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Demerol (Meperidine) Sales by Application (2016-2021) & (K MT)
Table 59. Middle East & Africa Demerol (Meperidine) Sales Market Share by Application (2016-2021)
Table 60. Global Demerol (Meperidine) Sales Forecast by Type (2021-2026) & (K MT)
Table 61. Global Demerol (Meperidine) Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Demerol (Meperidine) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Demerol (Meperidine) Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Demerol (Meperidine) Sales Forecast by Application (2021-2026) & (K MT)
Table 65. Global Demerol (Meperidine) Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Demerol (Meperidine) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Demerol (Meperidine) Revenue Market Share Forecast by Application (2021-2026)
Table 68. Purdue Pharma Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 69. Purdue Pharma Demerol (Meperidine) Product Offered
Table 70. Purdue Pharma Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 71. Purdue Pharma Main Business
Table 72. Purdue Pharma Latest Developments
Table 73. Egalet Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 74. Egalet Demerol (Meperidine) Product Offered
Table 75. Egalet Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 76. Egalet Main Business
Table 77. Egalet Latest Developments
Table 78. Boehringer Ingelheim Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Demerol (Meperidine) Product Offered
Table 80. Boehringer Ingelheim Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Janssen Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 84. Janssen Demerol (Meperidine) Product Offered
Table 85. Janssen Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 86. Janssen Main Business
Table 87. Janssen Latest Developments
Table 88. Sanofi Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Demerol (Meperidine) Product Offered
Table 90. Sanofi Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sun Pharmaceuticals Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 94. Sun Pharmaceuticals Demerol (Meperidine) Product Offered
Table 95. Sun Pharmaceuticals Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 96. Sun Pharmaceuticals Main Business
Table 97. Sun Pharmaceuticals Latest Developments
Table 98. Mallinckrodt Pharmaceuticals Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 99. Mallinckrodt Pharmaceuticals Demerol (Meperidine) Product Offered
Table 100. Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 101. Mallinckrodt Pharmaceuticals Main Business
Table 102. Mallinckrodt Pharmaceuticals Latest Developments
Table 103. Endo Pharmaceuticals Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 104. Endo Pharmaceuticals Demerol (Meperidine) Product Offered
Table 105. Endo Pharmaceuticals Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 106. Endo Pharmaceuticals Main Business
Table 107. Endo Pharmaceuticals Latest Developments
Table 108. Actavis Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 109. Actavis Demerol (Meperidine) Product Offered
Table 110. Actavis Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 111. Actavis Main Business
Table 112. Actavis Latest Developments
Table 113. Pfizer Basic Information, Demerol (Meperidine) Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Demerol (Meperidine) Product Offered
Table 115. Pfizer Demerol (Meperidine) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Demerol (Meperidine)
Figure 2. Demerol (Meperidine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Demerol (Meperidine) Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Demerol (Meperidine) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Demerol (Meperidine) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Demerol (Meperidine) Sales Market Share by Type in 2020
Figure 12. Global Demerol (Meperidine) Revenue Market Share by Type (2016-2021)
Figure 13. Demerol (Meperidine) Consumed in Anesthesia
Figure 14. Global Demerol (Meperidine) Market: Anesthesia (2016-2021) & (K MT)
Figure 15. Demerol (Meperidine) Consumed in Cough Treatment
Figure 16. Global Demerol (Meperidine) Market: Cough Treatment (2016-2021) & (K MT)
Figure 17. Demerol (Meperidine) Consumed in Diarrhea Treatment
Figure 18. Global Demerol (Meperidine) Market: Diarrhea Treatment (2016-2021) & (K MT)
Figure 19. Global Demerol (Meperidine) Sales Market Share by Application (2016-2021)
Figure 20. Global Demerol (Meperidine) Revenue Market Share by Application in 2020
Figure 21. Global Demerol (Meperidine) Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Demerol (Meperidine) Revenue Market Share by Company in 2020
Figure 23. Global Demerol (Meperidine) Sales Market Share by Regions (2016-2021)
Figure 24. Global Demerol (Meperidine) Revenue Market Share by Region in 2020
Figure 25. Americas Demerol (Meperidine) Sales 2016-2021 (K MT)
Figure 26. Americas Demerol (Meperidine) Revenue 2016-2021 ($ Millions)
Figure 27. APAC Demerol (Meperidine) Sales 2016-2021 (K MT)
Figure 28. APAC Demerol (Meperidine) Revenue 2016-2021 ($ Millions)
Figure 29. Europe Demerol (Meperidine) Sales 2016-2021 (K MT)
Figure 30. Europe Demerol (Meperidine) Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Demerol (Meperidine) Sales 2016-2021 (K MT)
Figure 32. Middle East & Africa Demerol (Meperidine) Revenue 2016-2021 ($ Millions)
Figure 33. Americas Demerol (Meperidine) Sales Market Share by Country in 2020
Figure 34. Americas Demerol (Meperidine) Revenue Market Share by Country in 2020
Figure 35. Americas Demerol (Meperidine) Sales Market Share by Type in 2020
Figure 36. Americas Demerol (Meperidine) Sales Market Share by Application in 2020
Figure 37. United States Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Demerol (Meperidine) Sales Market Share by Region in 2020
Figure 42. APAC Demerol (Meperidine) Revenue Market Share by Regions in 2020
Figure 43. APAC Demerol (Meperidine) Sales Market Share by Type in 2020
Figure 44. APAC Demerol (Meperidine) Sales Market Share by Application in 2020
Figure 45. China Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Demerol (Meperidine) Sales Market Share by Country in 2020
Figure 52. Europe Demerol (Meperidine) Revenue Market Share by Country in 2020
Figure 53. Europe Demerol (Meperidine) Sales Market Share by Type in 2020
Figure 54. Europe Demerol (Meperidine) Sales Market Share by Application in 2020
Figure 55. Germany Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Demerol (Meperidine) Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Demerol (Meperidine) Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Demerol (Meperidine) Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Demerol (Meperidine) Sales Market Share by Application in 2020
Figure 64. Egypt Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Demerol (Meperidine) Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

※본 조사보고서 [세계의 데메롤 (메페리딘) 시장예측 2021년-2026년] (코드 : LPI-2108K201259) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 데메롤 (메페리딘) 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 고지혈증 처방약 시장예측 2021년-2026년
LPI-2108K201466 / LP Information / 2021년 8월 / 본 조사보고서는 고지혈증 처방약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 만성형 성선 자극 호르몬 시장예측 2021년-2026년
LPI-2108K200012 / LP Information / 2021년 8월 / 본 조사보고서는 만성형 성선 자극 호르몬의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Chronic Gonadotropin will have significant change from previous year. By the most conservative estimates of global Chronic Gonadotropin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 무침 약물 전달 시스템 시장예측 2021년-2026년
LPI-2108K201631 / LP Information / 2021년 8월 / 본 조사보고서는 무침 약물 전달 시스템의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Needle-Free Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Needle-Free Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 세페타메트 피복실 태블릿 시장예측 2021년-2026년
LPI-2108K200006 / LP Information / 2021년 8월 / 본 조사보고서는 세페타메트 피복실 태블릿의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Cefetamet Pivoxil Tablets will have significant change from previous year. By the most conservative estimates of global Cefetamet Pivoxil Tablets market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항비만약 시장예측 2021년-2026년
LPI-2108K200019 / LP Information / 2021년 8월 / 본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 사이클로스포린 시장예측 2021년-2026년
LPI-2108K200008 / LP Information / 2021년 8월 / 본 조사보고서는 사이클로스포린의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Cyclosporine will have significant change from previous year. By the most conservative estimates of global Cyclosporine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 아티파메졸 시장예측 2021년-2026년
LPI-2108K201081 / LP Information / 2021년 8월 / 본 조사보고서는 아티파메졸의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Atipamezole will have significant change from previous year. By the most conservative estimates of global Atipamezole market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 칸시다스 시장예측 2021년-2026년
LPI-2108K201156 / LP Information / 2021년 8월 / 본 조사보고서는 칸시다스의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Cancidas will have significant change from previous year. By the most conservative estimates of global Cancidas market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 알레르기성 비염 시장예측 2021년-2026년
LPI-2108K202095 / LP Information / 2021년 8월 / 본 조사보고서는 알레르기성 비염의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Allergic Rhinitis will have significant change from previous year. By the most conservative estimates of global Allergic Rhinitis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 10860 million in 2019. Over...